Stephen George Dilly, Director at SANGAMO THERAPEUTICS, INC (SGMO), sold 35,000 shares at $6.00 ($210K) on 2020-03-19, disclosed to the SEC on 2020-03-20.
Open-market sale of $210k SGMO by Director. Not flagged as scheduled, tax-driven, or recurring — but no specific bearish signal from our filters. Reasons for insider sales vary widely.
Nothing distinguishes this filing.
| Filing → |
| SRRA | BUY | 2021-05-20 | $178K | — | Filing → |
| SGMO | SELL | 2020-03-18 | $90K | — | Filing → |
| AIMT | SELL | 2018-06-13 | $1.8M | — | Filing → |